Loading
Loading…
Loading…
| # | Schedule | Awarded To | Bids | Value |
|---|---|---|---|---|
| 1 | Schedule 1 | MEDICAL EQUIPMENT AND ENGG COMPANYLikely | 1 | ₹635.10 |
| 2 | Schedule 2 | MAHAJAN SCIENTIFIC & SURGICOLikely | 1 | ₹2,941.44 |
| 3 | Schedule 4 | SAI KIRPA SURGICALSLikely | 1 | ₹2,450.25 |
| 4 | Schedule 6 | MEDICAL EQUIPMENT AND ENGG COMPANYLikely | 1 | ₹9,000 |
| 5 | Schedule 7 | MEDICAL EQUIPMENT AND ENGG COMPANYLikely | 1 | ₹792 |
Tender Value
Refer Docs
EMD Value
Exempted
Closing Date
2 Dec 2024, 11:00 amClosed
INJ ETOPHYLLNE 84 point 7 plus THEOPHYLLINE 25 point 3 per ML
UROBAG
SOFOSUVIR 400 MG plus DACLATASAVIR 60 MG TAB
FUSIDIC ACID OINT or CREAM
INJ TT TETANUS TOXOID 5 ML
ED PILOCARPINE
SYP METOCLOPROMIDE HCL 5MG per 5ML BOTTLE OF 30 ML
BUVALOR BUPRENORPHINE PATCH 20 MCG
COLOSTOMY PASTE
DNS FLUID
ONDANSETRON SYP 2 MG per 5ML IN BOTT OF 30 ML
HYDROGEN PEROXYDE SOLUTION
ED FLUCONAZOLE 0 pont 3 percent
INJ METOCLOPRAMIDE 5MG per ML
INJ DICYCLOMINE 20 MG
ISOTONIC GLUSOSE SALINE
INJ ATROPINE 0 point 6 MG per 1 ML
SODIUM CHLORIDE 6 percent W per W EYE OINT HYPERSOL 6 percent
IBUPROFEN SYRUP 100 MG per 5 ML BOTT OF 50 ML
SYP PHENYTOIN SOD 200 ML
INJ CIPROFLOXACIN 200 MG per 100 ML
INJ TRANEXAMIC ACID
MAGNESIUM SULPHATE 50 percent W per V INJ
INJ CALCIUM GLUCONATE 10 percent Bid Number ( ) : GEM/2024/B/5593639 Dated : 11-11-2024 Bid Document 1/23
7122281
GEM/2024/B/5593639
Two Packet Bid
INJ ETOPHYLLNE 84 point 7 plus THEOPHYLLINE 25 point 3
28 days
Punjab; Jalandhar
Item wise evaluation
PRODUCT
7 documents required · 7 mandatory
3 yrs
₹31
80%
| Item | Delivery Location | Qty | Delivery |
|---|---|---|---|
| INJ ETOPHYLLNE 84 point 7 plus THEOPHYLLINE 25 point 3 per ML | JALANDHAR CITY | 219 | 28 days |
| UROBAG | JALANDHAR CITY | 192 | 28 days |
| SOFOSUVIR 400 MG plus DACLATASAVIR 60 MG TAB | JALANDHAR CITY | 168 | 28 days |
| FUSIDIC ACID OINT or CREAM | JALANDHAR CITY | 165 | 28 days |
| INJ TT TETANUS TOXOID 5 ML | JALANDHAR CITY | 62 | 28 days |
| ED PILOCARPINE | JALANDHAR CITY | 75 | 28 days |
| SYP METOCLOPROMIDE HCL 5MG per 5ML BOTTLE OF 30 ML | JALANDHAR CITY | 60 | 28 days |
| BUVALOR BUPRENORPHINE PATCH 20 MCG | JALANDHAR CITY | 60 | 28 days |
| COLOSTOMY PASTE | JALANDHAR CITY | 51 | 28 days |
| DNS FLUID | JALANDHAR CITY | 48 | 28 days |
| ONDANSETRON SYP 2 MG per 5ML IN BOTT OF 30 ML | JALANDHAR CITY | 36 | 28 days |
| HYDROGEN PEROXYDE SOLUTION | JALANDHAR CITY | 36 | 28 days |
| ED FLUCONAZOLE 0 pont 3 percent | JALANDHAR CITY | 30 | 28 days |
| INJ METOCLOPRAMIDE 5MG per ML | JALANDHAR CITY | 27 | 28 days |
| INJ DICYCLOMINE 20 MG | JALANDHAR CITY | 27 | 28 days |
| ISOTONIC GLUSOSE SALINE | JALANDHAR CITY | 21 | 28 days |
| INJ ATROPINE 0 point 6 MG per 1 ML | JALANDHAR CITY | 18 | 28 days |
| SODIUM CHLORIDE 6 percent W per W EYE OINT HYPERSOL 6 percent | JALANDHAR CITY | 15 | 28 days |
| IBUPROFEN SYRUP 100 MG per 5 ML BOTT OF 50 ML | JALANDHAR CITY | 15 | 28 days |
| SYP PHENYTOIN SOD 200 ML | JALANDHAR CITY | 15 | 28 days |
| INJ CIPROFLOXACIN 200 MG per 100 ML | JALANDHAR CITY | 6 | 28 days |
| INJ TRANEXAMIC ACID | JALANDHAR CITY | 3 | 28 days |
| MAGNESIUM SULPHATE 50 percent W per V INJ | JALANDHAR CITY | 3 | 28 days |
| INJ CALCIUM GLUCONATE 10 percent | JALANDHAR CITY | 3 | 28 days |
Exempted
9 Dec 2024
11 Nov 2024
2 Dec 2024
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_7122281.pdf
GEM_BID
cfa_re-125_noting_2024-11-11-09-51-06_89f6332d4d65030a7ec7c88d495bfb38.pdf
BOQ
boq_item_sample_file_2024-11-11-09-51-06_de1576439785b03d8ce2e62e151c4317.csv
BOQ
ATC_d10f895a-ddb8-4387-8e551731300163557_DGLPOIC.docx
OTHER
list-of-categories-where-trials-are-allowed_1712126171.pdf
OTHER
gtc.pdf
OTHER
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .